An observational study in Rhinitis, sponsored by Ajou University School of Medicine. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2016-05-02.
Sponsored by Ajou University School of Medicine · Observational
Korean linguistic adaptation of Rhinitis controlled assessment test (RCAT).
Check the Korean version of rhinitis controlled assessment tests, the total non-symptom scores (total nasal symptoms score, TNSS), rhinitis-related quality of life (RQLQ), rhinitis controlled degree, severity, and after study enrollment and 4 weeks treatment.
1,105 studies on the registry are indexed under Rhinitis; 65 are open to participants now.
This study's enrollment of 130 is close to the median of 141 across 172 observational studies indexed under Rhinitis.
Browse Rhinitis studies →Ajou University School of Medicine is the lead sponsor of 171 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
rhinitis within 12 months from the time of study enrollment.
Exclusion Criteria:
Check the Korean version of rhinitis controlled assessment tests, the total non-symptom scores (total nasal symptoms score, TNSS), rhinitis-related quality of life (RQLQ), rhinitis controlled degree, severity, and after study enrollment and 4 weeks treatment.
Also known as: questionnaire(R-CAT-RQLQ)
Korean linguistic adaptation of Rhinitis controlled assessment test (RCAT)
Check the Korean version of rhinitis controlled assessment tests
Time frame: up to 4weeks
rhinitis-related quality of life
rhinitis-related quality of life (RQLQ)check up to 24 weeks
Time frame: up to 4weeks
This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ajou University School of Medicine